Human African trypanosomiasis: clinical presentation and immune response.
about
Parasite-intrinsic factors can explain ordered progression of trypanosome antigenic variationClinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and UgandaDiscovery of Infection Associated Metabolic Markers in Human African TrypanosomiasisEstimates of the duration of the early and late stage of gambiense sleeping sicknessThe trypanosome transcriptome is remodelled during differentiation but displays limited responsiveness within life stages.Analysis of risk factors for T. brucei rhodesiense sleeping sickness within villages in south-east Uganda.Trypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis.The natural progression of Gambiense sleeping sickness: what is the evidence?A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patientsTip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling.Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infectionCardiac involvement with parasitic infections.High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosisStage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.Enolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites-perspectives for its use as a therapeutic target.Human African trypanosomiasis presenting at least 29 years after infection--what can this teach us about the pathogenesis and control of this neglected tropical disease?Evidence for recycling of invariant surface transmembrane domain proteins in African trypanosomesType I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes.An Overview of Trypanosoma brucei Infections: An Intense Host-Parasite Interaction.Pharmacogenomic implications of the evolutionary history of infectious diseases in AfricaEscape mechanisms of African trypanosomes: why trypanosomosis is keeping us awake.Maintenance of B cells during chronic murine Trypanosoma brucei gambiense infection.Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.Metabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense infection.Selenium metabolism in Trypanosoma: characterization of selenoproteomes and identification of a Kinetoplastida-specific selenoprotein.Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo.Novel lead compounds in pre-clinical development against African sleeping sickness
P2860
Q24681812-65717011-573A-4DFB-AC4B-C5E69C2A921EQ28477304-6C1E4B11-743A-4D94-BF2B-D7EBFFD9DDFEQ28550504-EA869394-64A8-477E-ACA7-6AD95C527DDFQ28755434-7CEDB79D-B4C0-4281-BA45-AD166A6B2C42Q33345915-40572BFB-79F4-41C7-9CF8-DA3952D9F282Q33347875-45E8AEDD-699F-45FC-BA86-3C67B9740E94Q33375071-CF6B5B47-FD9F-45B4-ADE4-F8C31A6E18EEQ33395342-18E20FFB-7651-498E-861B-D98F468F3C70Q33474338-1F5C484A-9D7A-4EDB-B13C-2321E2FC6051Q33660251-CB351FB3-8142-482E-A595-8D787D3FB772Q33747036-E72E87B4-A205-4221-9F23-30D0C91DE653Q33825602-E0A86FA6-C78D-4F73-A7AB-FC348D53637AQ33941028-54075CA5-1503-428B-860B-0D6177CF57D6Q34474577-C3DA065F-A6F5-410C-BD65-60CFB2267DF7Q34975047-4BA5663E-CFAE-4C38-B346-90AA365F36A7Q35529820-AC149A41-F5FF-4155-857D-63CD2C84D700Q36606847-3743676F-DFD5-41E7-BB80-63E4021EF846Q36972173-EC619823-D98F-4066-AA69-E7AD6099554CQ37531559-440FBD91-4FA1-4CBC-96D5-D19E6EA3DA27Q37737731-8BFDD036-3901-49F3-8939-F368AF48DFEAQ38283759-B807BCF4-1910-4BBF-9C29-874371D00D6EQ40633362-F7CF7CD5-EEC4-4DE0-AC3C-928D1CCBE2BDQ41354593-6FE5173A-2097-4562-9FB2-39A741C87E04Q41996448-2DF86350-CD91-4A32-8F24-C597118A2FD3Q42019802-E0DDBCD6-4C75-4927-B963-40AD82DAED19Q55322154-5FDC187E-5630-44FF-A0DA-040DE649D53EQ58842335-559F3524-BF9B-466D-984F-E220DB649184
P2860
Human African trypanosomiasis: clinical presentation and immune response.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Human African trypanosomiasis: clinical presentation and immune response.
@ast
Human African trypanosomiasis: clinical presentation and immune response.
@en
type
label
Human African trypanosomiasis: clinical presentation and immune response.
@ast
Human African trypanosomiasis: clinical presentation and immune response.
@en
prefLabel
Human African trypanosomiasis: clinical presentation and immune response.
@ast
Human African trypanosomiasis: clinical presentation and immune response.
@en
P2860
P1433
P1476
Human African trypanosomiasis: clinical presentation and immune response.
@en
P2093
Sternberg JM
P2860
P304
P356
10.1111/J.0141-9838.2004.00731.X
P577
2004-11-01T00:00:00Z